Fibroblast Activation Protein Expression in Sarcomas
Sarcoma · 09.06.2023 · 2023 · 1-11
DOI: 10.1155/2023/2480493 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sarcoma, erschienen am 09.06.2023. Verfasst von Jacquelyn N Crane und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Hematology, Oncology, Stem Cell Transplantation & Regenerative Medicine, Stanford University School o…. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Eli and Edythe Broad Foundation, Alan B. Slifka Foundation.
Abstract (Originalsprache)
Objectives
Fibroblast activation protein alpha (FAP) is highly expressed by cancer-associated fibroblasts in multiple epithelial cancers. The aim of this study was to characterize FAP expression in sarcomas to explore its potential utility as a diagnostic and therapeutic target and prognostic biomarker in sarcomas.
Methods
Available tissue samples from patients with bone or soft tissue tumors were identified at the University of California, Los Angeles. FAP expression was evaluated via immunohistochemistry (IHC) in tumor samples (n = 63), adjacent normal tissues (n = 30), and positive controls (n = 2) using semiquantitative systems for intensity (0 = negative; 1 = weak; 2 = moderate; and 3 = strong) and density (none, 75%) in stromal and tumor/nonstromal cells and using a qualitative overall score (not detected, low, medium, and high). Additionally, RNA sequencing data in publicly available databases were utilized to compare FAP expression in samples (n = 10,626) from various cancer types and evaluate the association between FAP expression and overall survival (OS) in sarcoma (n = 168).
Results
The majority of tumor samples had FAP IHC intensity scores ≥2 and density scores ≥25% for stromal cells (77.7%) and tumor cells (50.7%). All desmoid fibromatosis, myxofibrosarcoma, solitary fibrous tumor, and undifferentiated pleomorphic sarcoma samples had medium or high FAP overall scores. Sarcomas were among cancer types with the highest mean FAP expression by RNA sequencing. There was no significant difference in OS in patients with sarcoma with low versus high FAP expression.
Conclusion
The majority of the sarcoma samples showed FAP expression by both stromal and tumor/nonstromal cells. Further investigation of FAP as a potential diagnostic and therapeutic target in sarcomas is warranted.
Autor:innen und Institutionen
- Department of Pediatrics, Division of Pediatric Hematology, Oncology, Stem Cell Transplantation & Regenerative Medicine, Stanford University School of Medicine, 1000 Welch Rd, Suite 300, Palo Alto, CA 94304, USA.
- University of California Los Angeles, Department of Surgery, Los Angeles, CA, USA.
- University of California Los Angeles, Department of Molecular and Medical Pharmacology, Los Angeles, CA, USA.
- University of California Los Angeles, Department of Pathology and Laboratory Medicine, Los Angeles, CA, USA.
- University of California Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.
- University of California Los Angeles, Department of Pediatrics, Los Angeles, CA, USA.
ORCID-Profile: Jacquelyn N Crane
Förderung
- NCI NIH HHS
- Eli and Edythe Broad Foundation
- Alan B. Slifka Foundation
Zitieren
APA
Crane, J. N., Graham, D. S., Mona, C. E., Nelson, S. D., Samiei, A., Dawson, D. W., Dry, S. M., Masri, M. G., Crompton, J. G., Benz, M. R., Czernin, J., Eilber, F. C., Graeber, T. G., Calais, J., & Federman, N. C. (2023). Fibroblast Activation Protein Expression in Sarcomas. Sarcoma, 2023, 1-11. https://doi.org/10.1155/2023/2480493
Vancouver
Crane JN, Graham DS, Mona CE, Nelson SD, Samiei A, Dawson DW, et al. Fibroblast Activation Protein Expression in Sarcomas. Sarcoma. 2023;2023:1-11. doi:10.1155/2023/2480493
BibTeX
@article{Crane2023,
author = {Crane, Jacquelyn N and Graham, Danielle S and Mona, Christine E and Nelson, Scott D and Samiei, Alireza and Dawson, David W and Dry, Sarah M and Masri, Marwan G and Crompton, Joseph G and Benz, Matthias R and Czernin, Johannes and Eilber, Fritz C and Graeber, Thomas G and Calais, Jeremie and Federman, Noah C},
title = {Fibroblast Activation Protein Expression in Sarcomas},
journal = {Sarcoma},
year = {2023},
volume = {2023},
pages = {1--11},
doi = {10.1155/2023/2480493}
}
EUVIMED